Patent Issued for Devices and methods for detection and quantification of immunological proteins, pathogenic and microbial agents and cells (USPTO 12174179).

A patent has been issued for devices and methods developed by Carnegie Mellon University for the detection and quantification of immunological proteins, pathogenic and microbial agents, and cells. The technology aims to improve immunoassay tests by utilizing magnetic-responsive micro-beads in liquid solutions to detect and quantify analytes, reducing costs and complexity while increasing sensitivity. The patent outlines methods for detecting and quantifying micro-bead concentration and measuring DNA fragment concentration, addressing the need for portable, low-cost, and sensitive point-of-care immunoassay devices. [Extracted from the article]